Trial Profile
A Phase 1, Open-Label, Four-Period, Two-Sequence, Two-Treatment, Single Dose, Randomized, Crossover Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir in Healthy Adult Volunteers Under Fasting Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2020
Price :
$35
*
At a glance
- Drugs Ravidasvir (Primary) ; Ravidasvir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 18 Oct 2018 Status changed from recruiting to completed.
- 02 Aug 2018 New trial record